| MeSH term | MeSH ID | Detail |
|---|---|---|
| Atherosclerosis | D050197 | 85 associated lipids |
| Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Hypercholesterolemia | D006937 | 91 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Glioma | D005910 | 112 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Shan Y et al. | p38 MAPK plays a distinct role in sulforaphane-induced up-regulation of ARE-dependent enzymes and down-regulation of COX-2 in human bladder cancer cells. | 2010 | Oncol. Rep. | pmid:20204301 |
| Candido R et al. | Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. | 2010 | J. Vasc. Res. | pmid:19907187 |
| Nabipour I et al. | Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women. | 2010 | Metab. Clin. Exp. | pmid:19922962 |
| Barbagallo I et al. | Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation. | 2010 | J. Bone Miner. Metab. | pmid:19924377 |
| Takács I et al. | Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression. | 2010 | Eur. J. Endocrinol. | pmid:19934266 |
| Eriksen CG et al. | The expression of IL-6 by osteoblasts is increased in healthy elderly individuals: stimulated proliferation and differentiation are unaffected by age. | 2010 | Calcif. Tissue Int. | pmid:20820764 |
| Bitto A et al. | Evidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques. | 2010 | J. Vasc. Surg. | pmid:20719466 |
| Caidahl K et al. | Osteoprotegerin: a biomarker with many faces. | 2010 | Arterioscler. Thromb. Vasc. Biol. | pmid:20720194 |
| Cianciolo G et al. | Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index? | 2010 | Blood Purif. | pmid:19816015 |
| Pivonka P et al. | Theoretical investigation of the role of the RANK-RANKL-OPG system in bone remodeling. | 2010 | J. Theor. Biol. | pmid:19782692 |
| Ta HM et al. | Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21059944 |
| Riches PL and Ralston SH | Recent insights into the biology of bone turnover. | 2010 | J R Coll Physicians Edinb | pmid:21125043 |
| Son J et al. | cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction. | 2010 | Biochem. Biophys. Res. Commun. | pmid:20599715 |
| Horowitz MC et al. | How B cells influence bone biology in health and disease. | 2010 | Bone | pmid:20601290 |
| Nicolin V and Narducci P | Soluble TRAIL could enhance bone destruction acting on Rank-ligand in estrogen-independent human breast cancer cell line MDA-MB-231. | 2010 | Acta Histochem. | pmid:19058836 |
| Quercioli A et al. | Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling. | 2010 | Eur. J. Clin. Invest. | pmid:20497460 |
| Shaker OG et al. | Possible role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as markers of plaque instability in coronary artery disease. | 2010 | Angiology | pmid:20498140 |
| Dai J et al. | Reversal of chemotherapy-induced leukopenia using granulocyte macrophage colony-stimulating factor promotes bone metastasis that can be blocked with osteoclast inhibitors. | 2010 | Cancer Res. | pmid:20501834 |
| Wang EB et al. | [Histochemical and immunohistochemical double staining for osteolytic related factors in keratocystic odontogenic tumor]. | 2010 | Beijing Da Xue Xue Bao | pmid:20140051 |
| Schlieper G et al. | Analysis of calcifications in patients with coral reef aorta. | 2010 | Ann Vasc Surg | pmid:20144533 |
| Ruckh TT et al. | Osteogenic differentiation of bone marrow stromal cells on poly(epsilon-caprolactone) nanofiber scaffolds. | 2010 | Acta Biomater | pmid:20144747 |
| Gibbons CL et al. | Osteoclast-like cells in soft tissue leiomyosarcomas. | 2010 | Virchows Arch. | pmid:20127110 |
| Fei Q et al. | Osteogenic growth peptide enhances the proliferation of bone marrow mesenchymal stem cells from osteoprotegerin-deficient mice by CDK2/cyclin A. | 2010 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:20926513 |
| Reinhard H et al. | Osteoprotegerin and mortality in type 2 diabetic patients. | 2010 | Diabetes Care | pmid:20929997 |
| Trouvin AP and Goëb V | Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss. | 2010 | Clin Interv Aging | pmid:21228900 |
| Sun QF et al. | [Effects of high mobility group box 1 in activating periodontal ligament fibroblasts to express cytokine]. | 2010 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:20848944 |
| Nabipour I et al. | Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory. | 2009 Sep-Oct | Menopause | pmid:19387415 |
| Matsubara K et al. | Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease. | 2009 Nov-Dec | J. Nephrol. | pmid:19967657 |
| Tuchendler D and Bolanowski M | [The role of osteoprotegerin and vitamin D in thyroid pathology]. | 2009 Nov-Dec | Endokrynol Pol | pmid:20041365 |
| GÅ‚uszko P | [Effects of biologic antirheumatic treatments on bone metabolism in rheumatoid arthritis and ankylosing spondylitis]. | 2009 Mar-Apr | Endokrynol Pol | pmid:19396755 |
| Doschak MR et al. | Improved bone delivery of osteoprotegerin by bisphosphonate conjugation in a rat model of osteoarthritis. | 2009 Mar-Apr | Mol. Pharm. | pmid:19718808 |
| Corallini F et al. | Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin. | 2009 Jan-Mar | Eur J Histochem | pmid:19351609 |
| Kolar P et al. | Effects of celecoxib on the expression of osteoprotegerin, energy metabolism and cell viability in cultured human osteoblastic cells. | 2009 Jan-Feb | Clin. Exp. Rheumatol. | pmid:19327236 |
| Nihrane A et al. | Depletion of the Shwachman-Diamond syndrome gene product, SBDS, leads to growth inhibition and increased expression of OPG and VEGF-A. | 2009 Jan-Feb | Blood Cells Mol. Dis. | pmid:19014892 |
| Koshikawa M et al. | Elevated osteopontin levels in patients with peripheral arterial disease. | 2009 Feb-Mar | Angiology | pmid:18388057 |
| Le XK et al. | Porphyromonas gingivalis decreases osteoblast proliferation through IL-6-RANKL/OPG and MMP-9/TIMPs pathways. | 2009 Apr-Jun | Indian J Dent Res | pmid:19553712 |
| West SL et al. | The effect of exercise and estrogen on osteoprotegerin in premenopausal women. | 2009 | Bone | pmid:18929691 |
| Tada T et al. | Oral squamous cell carcinoma cells modulate osteoclast function by RANKL-dependent and -independent mechanisms. | 2009 | Cancer Lett. | pmid:18930344 |
| Moran CS et al. | Interaction between angiotensin II, osteoprotegerin, and peroxisome proliferator-activated receptor-gamma in abdominal aortic aneurysm. | 2009 | J. Vasc. Res. | pmid:18931513 |
| Schofer MD et al. | Influence of nanofibers on the growth and osteogenic differentiation of stem cells: a comparison of biological collagen nanofibers and synthetic PLLA fibers. | 2009 | J Mater Sci Mater Med | pmid:18987945 |
| Xu M et al. | Low-intensity pulsed laser irradiation affects RANKL and OPG mRNA expression in rat calvarial cells. | 2009 | Photomed Laser Surg | pmid:18800943 |
| Norian JM et al. | Low serum osteoprotegerin levels in premenopausal infertile women with low bone density: an association of relevance? | 2009 | Fertil. Steril. | pmid:18490014 |
| Kiechl S et al. | Denosumab, osteoporosis, and prevention of fractures. | 2009 | N. Engl. J. Med. | pmid:19940304 |
| Gürkan A et al. | Therapeutic efficacy of vasoactive intestinal peptide in escherichia coli lipopolysaccharide-induced experimental periodontitis in rats. | 2009 | J. Periodontol. | pmid:19792856 |
| Spencer AY and Lallier TE | Mechanical tension alters semaphorin expression in the periodontium. | 2009 | J. Periodontol. | pmid:19792857 |
| Greiner S et al. | Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating. | 2009 | J Biomed Mater Res A | pmid:18980195 |
| Harinarayan CV | Crohn's disease & osteoimmunology--is vitamin D the cross-talk co-ordinator? | 2009 | Indian J. Med. Res. | pmid:19797805 |
| Katopodis H et al. | MG-63 osteoblast-like cells enhance the osteoprotegerin expression of PC-3 prostate cancer cells. | 2009 | Anticancer Res. | pmid:19846944 |
| Trombone AP et al. | Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection. | 2009 | J. Periodont. Res. | pmid:18973535 |
| Sanchez C et al. | Mechanical loading highly increases IL-6 production and decreases OPG expression by osteoblasts. | 2009 | Osteoarthr. Cartil. | pmid:18974013 |
| Chanda D et al. | Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis. | 2009 | Clin. Cancer Res. | pmid:19920103 |
| Hozumi A et al. | Bone marrow adipocytes support dexamethasone-induced osteoclast differentiation. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19324007 |
| Palazzuoli A et al. | Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: relation to coronary artery disease extension. | 2009 | Int. J. Cardiol. | pmid:18707771 |
| Reid P and Holen I | Pathophysiological roles of osteoprotegerin (OPG). | 2009 | Eur. J. Cell Biol. | pmid:18707795 |
| Kanzaki S et al. | Bisphosphonate therapy ameliorates hearing loss in mice lacking osteoprotegerin. | 2009 | J. Bone Miner. Res. | pmid:18715136 |
| Atkins GJ et al. | Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. | 2009 | Osteoporos Int | pmid:18763010 |
| Nuche-Berenguer B et al. | Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states. | 2009 | Calcif. Tissue Int. | pmid:19219381 |
| Baud'huin M et al. | Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival. | 2009 | J. Biol. Chem. | pmid:19758994 |
| Rifas L and Weitzmann MN | A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner. | 2009 | Arthritis Rheum. | pmid:19877052 |
| Bargnoux AS et al. | Evolution of coronary artery calcifications following kidney transplantation: relationship with osteoprotegerin levels. | 2009 | Am. J. Transplant. | pmid:19775319 |
| Dalle Carbonare L et al. | Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. | 2009 | Arthritis Rheum. | pmid:19877060 |
| Krajewski AC et al. | Influence of lipopolysaccharide and interleukin-6 on RANKL and OPG expression and release in human periodontal ligament cells. | 2009 | APMIS | pmid:19775343 |
| Hamed AA and Fayad JN | Presence of otosclerosis and paget lesions in the same temporal bone. | 2009 | Otol. Neurotol. | pmid:19779387 |
| Golledge J et al. | A single-nucleotide polymorphism in the gene encoding osteoprotegerin is associated with diastolic blood pressure in older men. | 2009 | Am. J. Hypertens. | pmid:19779468 |
| Schett G et al. | Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis. | 2009 | Arthritis Rheum. | pmid:19714640 |
| Ryser MD et al. | Mathematical modeling of spatio-temporal dynamics of a single bone multicellular unit. | 2009 | J. Bone Miner. Res. | pmid:19063683 |
| Kadow-Romacker A et al. | Effect of mechanical stimulation on osteoblast- and osteoclast-like cells in vitro. | 2009 | Cells Tissues Organs (Print) | pmid:19033679 |
| Rauner M et al. | The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio. | 2009 | J. Rheumatol. | pmid:19040304 |
| Buijs JT et al. | Inhibition of bone resorption and growth of breast cancer in the bone microenvironment. | 2009 | Bone | pmid:19041433 |
| Giner M et al. | RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis. | 2009 | J. Steroid Biochem. Mol. Biol. | pmid:19073256 |
| Zauli G et al. | Role of full-length osteoprotegerin in tumor cell biology. | 2009 | Cell. Mol. Life Sci. | pmid:19011755 |
| Yasuhara R et al. | Lysine-specific gingipain promotes lipopolysaccharide- and active-vitamin D3-induced osteoclast differentiation by degrading osteoprotegerin. | 2009 | Biochem. J. | pmid:19102726 |
| Lee JS et al. | Changes in serum levels of receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, IL-6 and TNF-alpha in patients with a concomitant head injury and fracture. | 2009 | Arch Orthop Trauma Surg | pmid:18427820 |
| Graciolli FG et al. | Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia. | 2009 | Nephrol. Dial. Transplant. | pmid:19075196 |
| Turk N et al. | Proinflammatory cytokines and receptor activator of nuclear factor kappaB-ligand/osteoprotegerin associated with bone deterioration in patients with Crohn's disease. | 2009 | Eur J Gastroenterol Hepatol | pmid:19098682 |
| McGonigle JS et al. | Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function. | 2009 | Angiogenesis | pmid:19105036 |
| Kwok SK et al. | Circulating osteoprotegerin levels are elevated and correlated with antiphospholipid antibodies in patients with systemic lupus erythematosus. | 2009 | Lupus | pmid:19151114 |
| Ren W et al. | Effect of oral erythromycin therapy in patients with aseptic loosening of joint prostheses. | 2009 | Bone | pmid:19154802 |
| Chiba Y et al. | Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women. | 2009 | Gerontology | pmid:19158438 |
| Murthy RK et al. | Bone biology and the role of the RANK ligand pathway. | 2009 | Oncology (Williston Park, N.Y.) | pmid:20128323 |
| Hazenberg JG et al. | Microdamage detection and repair in bone: fracture mechanics, histology, cell biology. | 2009 | Technol Health Care | pmid:19478407 |
| Morena M et al. | A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients. | 2009 | Nephrol. Dial. Transplant. | pmid:19574342 |
| Schnabel RB et al. | Relation of multiple inflammatory biomarkers to incident atrial fibrillation. | 2009 | Am. J. Cardiol. | pmid:19576326 |
| Geusens P | Emerging treatments for postmenopausal osteoporosis - focus on denosumab. | 2009 | Clin Interv Aging | pmid:19554095 |
| Sampaio MS et al. | Expression of eight genes of nuclear factor-kappa B pathway in multiple myeloma using bone marrow aspirates obtained at diagnosis. | 2009 | Histol. Histopathol. | pmid:19554506 |
| Booij-Vrieling HE et al. | Inflammatory cytokines and the nuclear vitamin D receptor are implicated in the pathophysiology of dental resorptive lesions in cats. | 2009 | Vet. Immunol. Immunopathol. | pmid:19556012 |
| Alonso V et al. | Phytoestrogen modulation of bone-related cytokines and its impact on cell viability in human prostate cancer cells. | 2009 | Life Sci. | pmid:19632246 |
| Sauer AV et al. | ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency. | 2009 | Blood | pmid:19633200 |
| Narducci P et al. | Interaction of human recombinant tumor necrosis factor-related apoptosis-inducing ligand and osteoprotegerin could contribute to enhancement of the erosive processes induced by human synovial cells. | 2009 | J. Rheumatol. | pmid:19671825 |
| Patiño-GarcÃa A et al. | Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. | 2009 | Clin. Cancer Res. | pmid:19671856 |
| Spahni AI et al. | Immunohistochemical localization of RANK, RANKL and OPG in healthy and arthritic canine elbow joints. | 2009 | Vet Surg | pmid:19674422 |
| Mesquita M et al. | Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease. | 2009 | Clin. Chem. Lab. Med. | pmid:19676147 |
| Sotillo Rodriguez JE et al. | Enhanced osteoclastogenesis causes osteopenia in twisted gastrulation-deficient mice through increased BMP signaling. | 2009 | J. Bone Miner. Res. | pmid:19419314 |
| Yamaguchi M | RANK/RANKL/OPG during orthodontic tooth movement. | 2009 | Orthod Craniofac Res | pmid:19419454 |
| Neves JS et al. | Immunolocalization of CSF-1, RANKL and OPG in the enamel-related periodontium of the rat incisor and their implications for alveolar bone remodeling. | 2009 | Arch. Oral Biol. | pmid:19419711 |
| Gasowska K et al. | The influence of unfractionated and low-molecular weight heparins on the properties of human umbilical vein endothelial cells (HUVEC). | 2009 | Folia Histochem. Cytobiol. | pmid:19419932 |
| Ali Z et al. | Association of serum osteoprotegerin with ankle-brachial index and urine albumin: creatinine ratio in African-Americans and non-Hispanic whites. | 2009 | Atherosclerosis | pmid:19423112 |
| Alexander MY | RANKL links arterial calcification with osteolysis. | 2009 | Circ. Res. | pmid:19423860 |
| Nakamura M et al. | [Osteoclastogenesis and bone resorption]. | 2009 | Nippon Rinsho | pmid:19432105 |
| Masuda H and Tanaka S | [Drugs under development for osteoporosis ]. | 2009 | Nippon Rinsho | pmid:19432120 |